`

ITB-MED

Biotechnology Research

Specialities :
Transplantation surgery
Immunology
And monoclonal antibodies
Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$67.0M
size-icon Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About ITB-MED

What does Itb-med do?+

ITB-MED is developing the proprietary antagonistic CD2-directed monoclonal antibody, TCD601 (siplizumab), for several indications. ITB-MED is wholly committed to advancing and exploring the potential of TCD601, with a particular focus on its applications in transplantation and autoimmunity. The efforts extend to comprehensive worldwide clinical trials. ITB-MED is actively investigating further preclinical therapies to expand the reach of its novel immune-modulating approaches

What are Itb-med's specialties? +

Transplantation surgery,immunology,and monoclonal antibodies

What is Itb-med's industry? +

Itb-med operates in the Biotechnology research industry.

What is Itb-med's revenue? +

Itb-med's revenue is 11m - 100m

What is Itb-med's company size? +

Itb-med has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free